| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |